Krystal Biotech Inc.

In News

Krystal Biotech Announces RMAT Designation Granted by FDA - GlobeNewswire

GlobeNewswire - Feb 09, 2026

Krystal Biotech wins FDA RMAT status for cancer drug (KRYS) - Seeking Alpha

Seeking Alpha - Feb 09, 2026

FDA backs KB707 lung cancer immunotherapy with RMAT designation - stocktitan.net

stocktitan.net - Feb 09, 2026

Krystal Biotech Says US FDA Grants Regenerative Medicine Advanced Therapy Designation to Lung Cancer Treatment - marketscreener.com

marketscreener.com - Feb 09, 2026

Krystal Biotech (KRYS) Gains FDA RMAT Status for Innovative Lung Cancer Therapy - GuruFocus

GuruFocus - Feb 09, 2026

Vyjuvek Growth Powers Krystal Biotech’s (KRYS) Huge Upward Analyst Target Price Revision - Yahoo Finance

Yahoo Finance - Feb 04, 2026

Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: Should You Buy? - MSN

MSN - Feb 06, 2026

FDA grants RMAT designation to Krystal Biotech’s lung cancer therapy By Investing.com - Investing.com India

Investing.com India - Feb 09, 2026

Are You Looking for a Top Momentum Pick? Why Krystal Biotech, Inc. (KRYS) is a Great Choice - Nasdaq

Nasdaq - Jan 23, 2026

Assessing Krystal Biotech (KRYS) Valuation After Analyst Optimism On Vyjuvek Expansion And Ophthalmic Pipeline - Sahm

Sahm - Feb 03, 2026

Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation - CGTLive®

CGTLive® - Oct 15, 2025

What Does Wall Street Think About Krystal Biotech (KRYS)? - Yahoo Finance

Yahoo Finance - Jan 19, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment